IBEX (IBEX) grants 4,400 RSUs to Chief Sales/Marketing Officer

Rhea-AI Filing Summary

IBEX Ltd reported that Chief Sales/Marketing Officer Julie K. Casteel acquired 4,400 restricted stock units (RSUs) representing common shares. Each RSU converts into one common share as it vests. After this grant, she holds 121,194 common shares directly.

According to the award terms, 25% of the RSUs vest on July 1, 2026, with an additional 25% vesting on the same date in each of the following three years, provided she remains in continuous service. On each vesting date, shares of common stock will be automatically withheld to cover tax withholding obligations in a non‑discretionary transaction.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Casteel Julie K

Role Chief Sales/Marketing Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	4,400	$0.00	--

Holdings After Transaction: Common Shares — 121,194 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Casteel Julie K

(Last) (First) (Middle)

C/O IBEX LIMITED

1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)

WASHINGTON DC 20006

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Sales/Marketing Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	02/26/2026		A		4,400(1)	A	$0(1)	121,194	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. 25% of the RSUs vest on July 1, 2026, with 25% of the RSUs vesting annually thereafter for the following three years, provided that the Reporting Person remains in continuous service on each vesting date. Unless otherwise provided, on each vesting date shares of Common Stock will automatically be withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.

Remarks:

	Lisa Lenstrohm, Attorney-in-Fact	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did IBEX (IBEX) report for Julie K. Casteel?

IBEX reported that Chief Sales/Marketing Officer Julie K. Casteel received a grant of 4,400 restricted stock units representing common shares. These RSUs are a form of equity compensation that convert into one share of common stock per unit as they vest over time.

What is the vesting schedule for the 4,400 RSUs granted at IBEX?

The 4,400 RSUs vest over four years. 25% vest on July 1, 2026, and another 25% vest annually on the same date for the next three years, contingent on Julie K. Casteel’s continuous service through each vesting date.

How many IBEX common shares does Julie K. Casteel hold after this grant?

Following the RSU grant, Julie K. Casteel is reported to beneficially own 121,194 IBEX common shares directly. This figure reflects her holdings after the 4,400 restricted stock units were awarded, as disclosed in the insider transaction report.

How will taxes be handled on the IBEX RSUs granted to Julie K. Casteel?

On each vesting date, IBEX will automatically withhold shares of common stock to satisfy Julie K. Casteel’s tax withholding obligations. This withholding occurs in a non‑discretionary transaction, meaning the shares are retained by the issuer rather than sold on the market.

What type of security was granted in the IBEX insider Form 4 filing?

The filing shows a grant of restricted stock units tied to IBEX common shares. Each RSU represents a contingent right to receive one common share upon vesting, aligning the Chief Sales/Marketing Officer’s compensation with long‑term shareholder interests through equity-based awards.